SANGAMO THERAPEUTICS, INC Insider Trading for April 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SANGAMO THERAPEUTICS, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SANGAMO THERAPEUTICS, INC for April 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Option Exercise | M | 6.82 | 25,000 | 170,500 | 100,000 | |
| Apr 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Sell | S | 15.33 | 25,000 | 383,260 | 235,000 | 260 K to 235 K (-9.62 %) |
| Apr 17 2015 | SGMO | SANGAMO BIOSCIENCE ... | LANPHIER EDWARD O II | President & CEO | Buy | M | 6.82 | 25,000 | 170,500 | 260,000 | 235 K to 260 K (+10.64 %) |
| Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Option Exercise | M | 3.45 | 10,000 | 34,500 | 142,000 | |
| Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.37 | 1,029 | 15,813 | 202,849 | 203.9 K to 202.8 K (-0.50 %) |
| Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.43 | 971 | 14,984 | 203,878 | 204.8 K to 203.9 K (-0.47 %) |
| Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Sell | S | 15.30 | 10,000 | 152,974 | 204,849 | 214.8 K to 204.8 K (-4.65 %) |
| Apr 14 2015 | SGMO | SANGAMO BIOSCIENCE ... | Wolff Henry Ward | Exec VP & CFO | Buy | M | 3.45 | 10,000 | 34,500 | 214,849 | 204.8 K to 214.8 K (+4.88 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Option Exercise | M | 3.45 | 15,000 | 51,750 | 80,798 | |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Sell | S | 14.94 | 15,000 | 224,172 | 95,376 | 110.4 K to 95.4 K (-13.59 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | ANDO DALE G | VP, Therapeutic Dev ... | Buy | M | 3.45 | 15,000 | 51,750 | 110,376 | 95.4 K to 110.4 K (+15.73 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Option Exercise | M | 6.41 | 2,200 | 14,102 | 1,200 | |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Sell | S | 14.95 | 2,200 | 32,881 | 800 | 3 K to 800 (-73.33 %) |
| Apr 08 2015 | SGMO | SANGAMO BIOSCIENCE ... | RINGO WILLIAM R | Director | Buy | M | 6.41 | 2,200 | 14,102 | 3,000 | 800 to 3 K (+275.00 %) |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.70 | 7,000 | 39,900 | 38,172 | |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 5.35 | 5,000 | 26,750 | 30,000 | |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Option Exercise | M | 3.45 | 3,000 | 10,350 | 22,500 | |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Sell | S | 15.15 | 15,000 | 227,192 | 116,410 | 131.4 K to 116.4 K (-11.41 %) |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.70 | 7,000 | 39,900 | 131,410 | 124.4 K to 131.4 K (+5.63 %) |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 5.35 | 5,000 | 26,750 | 124,410 | 119.4 K to 124.4 K (+4.19 %) |
| Apr 03 2015 | SGMO | SANGAMO BIOSCIENCE ... | Gregory Philip D | SVP of Research & C ... | Buy | M | 3.45 | 3,000 | 10,350 | 119,410 | 116.4 K to 119.4 K (+2.58 %) |